A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.
about
A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A double-blind, randomised, pl ...... factors of metabolic syndrome.
@en
A double-blind, randomised, pl ...... factors of metabolic syndrome.
@nl
type
label
A double-blind, randomised, pl ...... factors of metabolic syndrome.
@en
A double-blind, randomised, pl ...... factors of metabolic syndrome.
@nl
prefLabel
A double-blind, randomised, pl ...... factors of metabolic syndrome.
@en
A double-blind, randomised, pl ...... factors of metabolic syndrome.
@nl
P2860
P50
P356
P1433
P1476
A double-blind, randomised, pl ...... factors of metabolic syndrome.
@en
P2093
Dennis H Chang
Nerida L Klupp
P2860
P2888
P356
10.1038/SREP29540
P407
P577
2016-08-11T00:00:00Z
P6179
1018879504